C hronic inflammation in arteries takes many forms and the causes vary markedly. The most common form of arterial inflammation is atherosclerosis, where inflammation is generally limited to the neointima and sometimes the medial layer of medium and larger arteries. However, the deeper layers of arteries can also become inflamed as well. Giant cell arteritis (GCA) constitutes an example of chronic inflammation that may often affect all layers of the arterial wall, including the adventitia. 1 The rapidly evolving concentric hyperplastic vascular lesions of GCA typically occur in large branches of the aorta, particularly the carotid and temporal arteries. 1 Clinical features of GCA are generally the result of the downstream tissue ischemia caused by luminal obstruction and may be rather modest (eg, headaches) but can include blindness, jaw claudication, aneurysm, arterial rupture, stroke, and death. 1 The diagnosis can be confirmed by biopsy, and diseased tissues exhibit a granulomatous panarteritis and the presence of giant cells (hence, the name). 1 Inflammatory lesions in GCA consist of activated T cells, dendritic cells (DCs), and macrophages. 2 The causes of GCA are not well understood, but as is the case with other forms of arterial inflammation, GCA appears to involve a breakdown of tolerance that seems to result from some interaction between host defenses and the arterial wall. 3 Hence, GCA reflects features of autoimmune phenomena, as well as primary immune defects, but the details of both are unclear.
Recently, major advances have been made in understanding the pathogenesis of GCA, implicating adaptive immunity, particularly DCs, as an integral part. DCs are specialized antigen-presenting cells, which are required as potent T-cell activators in each immune response against pathogens. 4 DCs are equipped with pattern recognition receptors, particularly Toll-like receptors (TLRs), which recognize microbial motifs, induce DC maturation, and subsequently acquire the ability to activate T cells against the pathogen. 4 In normal uninflamed arteries, immature and resting myeloid DCs are located in a ring-like structure around the adventitia-media border, which suggests that DCs are sentinels that form part of the first-line immune defense in the vessel wall. 2 In bioengineered human macrovessels, wall-embedded DCs but not monocytes or macrophages can trigger an intramural adaptive immune response. 5 During GCA, the number of vascular myeloid DCs significantly increases in the adventitia of affected arteries. 5 The activation of myeloid DCs is believed to be the first critical step in the pathogenesis of GCA. 2 Although the reasons for the activation of these myeloid DCs are unknown, some investigators suggest that infection with Chlamydia pneumoniae may be a contributing factor. 6 The important role of vascular DCs for the immune response in GCA was shown previously in temporal artery-SCID mouse chimeras. Whereas stimulation of vascular myeloid DCs with lipopolysaccharide (via TLR-4) led to a significant recruitment of activated CD4 ϩ T cells in the adventitia, 7 specific suppression of myeloid DCs using an anti-CD83 antibody completely abrogated vascular inflammation in GCA. 3 Recently, Pryshchep et al described a distinct expression pattern of TLR 1 to 9 on myeloid and plasmacytoid DCs dependent on the anatomic localization of the artery. 7 Remarkably, the unique TLR profile of each vascular territory suggests a specialization in immunosensing functions. 7 This fact raises the question whether activation of DC via different TLRs results in a similar or distinct vascular immune response.
New data now reported in this issue of Circulation Research by Deng et al 8 provide the answer to this question. The study also provides major new insights into what specific populations of lymphocytes may be doing in GCA pathophysiology, and the data suggest a kind of misguided or even deadly dance between DCs and T cells that depends on signals relayed by TLRs on both cell types. In their experiments, Deng et al used an elegant animal model of GCA, transferring human temporal arterial specimens subcutaneously into SCID mice. Subsequently, stimulation with a broad panel of TLR ligands was performed, and the recruitment and activation of adoptively transferred alloreactive CD4 ϩ T cells was analyzed. Ligation of TLR-4 (lipopolysaccharide) and TLR-5 (flagellin) were shown to be followed by DC maturation at the adventitia-media border and vascular invasion of CD4 ϩ T cells. In contrast, ligation of TLR-2/6 (LTA), TLR-3 (Poly I:C), and TLR-9 (CpG) failed to induce vascular inflammation.
Comparing the results on TLR-4 and TLR-5 ligation, Deng et al observed a basic difference in the vascular immune response. 8 Stimulation via TLR-4 induced the recruitment of T cells into all vascular layers (panarteritis), whereas on TLR-5 ligation T cell recruitment was restricted to the adventitia (perivasculitis). The authors observed that lipo-polysaccharide but not flagellin strongly upregulates the chemokine CCL20 and its corresponding receptor CCR-6 on T cells. In further functional experiments, Deng et al show that the interaction of CCL20 with CCR-6 is essential for the development of a full-blown panarteritis with destruction of the vessel wall. 8 This study examines the biological consequences of exposing one vascular bed, temporal arteries to different TLR ligands to determine whether the artery has only a universal response pattern and if various TLR ligands will initiate the same type of vascular inflammation? The data presented in this report provide evidence that pathogen-sensing by human temporal arteries can have markedly different biological outcomes. 8 TLR-4 agonists initiate a panarteritis whereas TLR-5 ligands produce perivasculitis. This is an important issue clinically in vasculitis. The present study provides data that the mode of action of vascular DCs can guide the emerging inflammation into opposing directions. This is the first observation that the developing vessel wall inflammation is fundamentally different depending on the initial innate immune signal.
How do these results affect our present knowledge of other chronic inflammatory vascular diseases? (1) In both Takayasu's arteritis and Kawasaki disease, vascular lesions of the aorta or coronary arteries are densely infiltrated with mature myeloid DCs that cluster with T cells, suggesting a DC-initiated, antigen-specific immune response in those vasculopathies. 9, 10 (2) Comparing atherosclerosis with classic vasculitides, it is surprising how many similar immunologic features they share. During atherosclerosis, immune competent cells, particularly myeloid DCs, macrophages, and T cells, are recruited into the vessel wall, and their presence is associated with plaque destabilization. [11] [12] [13] As in GCA, "trapping" induced by dyslipidemia contributes to the accumulation of DCs in atherosclerotic lesions. 14 The role of TLRs (TLR-4 and TLR-2) and vascular DCs are important in atherosclerosis, as well as infection-induced acceleration of atherosclerosis, and TLR4, TLR-2, or MyD88 knockout mice have significantly reduced atherosclerosis. 15 In atherosclerotic lesions, all preconditions are fulfilled that are necessary for the induction of an autoimmune response, and indeed, clonal expansion of CD4 ϩ T cells, reactive to oxidized LDL cholesterol, have been described. 16 However, there are also some differences between immune responses typical of atherosclerosis and other vasculitides. In atherosclerosis, the interaction of immune cells occurs in the intima, whereas GCA is mainly restricted to the adventitia. The reason for this distinct location of the vascular immune response is still unknown but might be associated with the presence of intimal neovessels in atherosclerosis, which may serve as possible entry for circulating immune cells. Also, in contrast to other vasculitides, plasmacytoid DCs are more frequently present in atherosclerotic lesions and are activated via TLR-9, thus amplifying cytolytic T-cell functions. 17 Correspondingly, in stable coronary artery disease, their vascular recruitment is accompanied by their peripheral decrease. 18, 19 The emergence of plasmacytoid DCs in atherosclerotic lesions raises the question if chronic viral infections might contribute to atherogenesis.
The study by Deng et al clearly shows the important interactions of DCs with 2 T's: T cells and TLRs. 8 The interaction of DCs and T cells is required for vascular immune responses like a man and a women dancing a tango to the music played by various musicians (TLRs) of an orchestra (innate immune system). Variation of that music might allow us in the future to modulate T-cell responses in vascular diseases suppressing inflammation and destruction of the vessel wall.
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